Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?

Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?

Objectives: SARS-CoV-2 is responsible for the global COVID-19 pandemic, with little prevention or treatment options. More than 600 million mortalities have been documented from SARS-CoV-2 infection, with the majority of fatalities occurring among elderly patients (aged >65 years). A number of vac...

Full description

Bibliographic Details
Main Authors:	Yiran E. Li, Shuyi Wang, Russel J. Reiter, Jun Ren
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	International Journal of Infectious Diseases
Subjects:	SARS-CoV-2 COVID-19 vaccines Cardiovascular Myocarditis Pericarditis Thrombotic thrombocytopenia
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971222004982

Similar Items

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
by: Rana I. Oueijan, et al.
Published: (2022-08-01)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01)

COVID-19 VACCINE-ASSOCIATED MYOCARDITIS (RUSSIAN TRANSLATION)
by: M. C. Morgan, et al.
Published: (2022-12-01)

Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
by: Young Shil Park
Published: (2021-08-01)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
by: Minglong Li, et al.
Published: (2022-08-01)

Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation
by: Domenico Filomena, et al.
Published: (2022-07-01)

Cardiovascular Involvement in Tuberculosis: From Pathophysiology to Diagnosis and Complications—A Narrative Review
by: Dragos Traian Marius Marcu, et al.
Published: (2023-01-01)

Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
by: Hung-Chen Lin, et al.
Published: (2023-02-01)

A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
by: Abhinandan Chittal, et al.
Published: (2021-11-01)

Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01)

Similarities and differences of cardiovascular complications of COVID-19 infection and COVID-19 vaccination
by: Đenić Aleksandar
Published: (2022-01-01)

Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know?
by: Alfredo Parra-Lucares, et al.
Published: (2021-12-01)

Cardiac Adverse Events after Vaccination—A Systematic Review
by: Kanak Parmar, et al.
Published: (2022-04-01)

Case Series of Potential Cardiac Inflammation Associated With Various SARS-CoV-2 Vaccinations Assessed by Cardiac MRI
by: Constantin Jahnke, et al.
Published: (2022-04-01)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
by: Rima Hajjo, et al.
Published: (2021-10-01)

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
by: Minghui Li, et al.
Published: (2021-10-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Myopericarditis following both BNT162b2 and NVX-CoV2373
by: Saima Ahmad, et al.
Published: (2022-12-01)

High dose cytarabine induced myopericarditis: When the heart debilitates but the fight against cancer must be strong
by: Villa-Saldarriaga, María P, et al.
Published: (2022-04-01)

Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
by: Archrob Khuhapinant, et al.
Published: (2021-09-01)

Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy
by: Giovanni Corrao, et al.
Published: (2022-11-01)

A rare case of COVID-19 vaccine-induced myopericarditis in a young adult
by: Arman Sharbatdaran, MD, et al.
Published: (2022-06-01)

Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19
by: Antonin Trimaille, et al.
Published: (2021-11-01)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
by: Abdallah Alami, et al.
Published: (2023-07-01)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
by: Wei-Ju Su, et al.
Published: (2023-06-01)

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
by: William W. King, et al.
Published: (2021-08-01)

COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review
by: Naim Mahroum, et al.
Published: (2022-07-01)

Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
by: Shane P. Comer, et al.
Published: (2022-02-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
by: Ortal Tuvali, et al.
Published: (2022-04-01)

Inflammatory heart diseases in children
by: Biljana Milinković, et al.
Published: (2019-12-01)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021-11-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
by: Milo Gatti, et al.
Published: (2021-01-01)

Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
by: Alessandra Piras, et al.
Published: (2022-09-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
by: Giuseppe Calcaterra, et al.
Published: (2021-09-01)

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
by: Sophie H. Bots, et al.
Published: (2022-11-01)